Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-03Clinical Trial Results: Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients With Urothelial Carcinoma (MORPHEUS-UC) [Phase 1, Phase 2]
Results from a Phase 1/2 study evaluating several immunotherapy-based treatments and combinations in patients with urothelial carcinoma (bla…
-
CLINICAL_TRIALS trial_result · 2026-07-22Clinical Trial Update: Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866) [Phase 3]
Phase 3 trial evaluating perioperative pembrolizumab plus neoadjuvant chemotherapy versus perioperative placebo plus neoadjuvant chemotherap…
-
CLINICAL_TRIALS trial_result · 2026-07-07Clinical Trial Results: Project HERO: Health Empowerment & Recovery Outcomes [NA]
Clinical trial results for Project HERO investigating health empowerment and recovery outcomes in cancer patients; study completed and resul…
-
CLINICAL_TRIALS trial_result · 2026-06-05Clinical Trial Update: A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC) [Phase 3]
Phase 3 clinical trial evaluating TAR-200 with cetrelimab or TAR-200 alone versus intravesical BCG in BCG-naïve high-risk non-muscle invasiv…
-
CLINICAL_TRIALS trial_result · 2026-06-02Clinical Trial Results: Study of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread [Phase 3]
Phase 3 trial comparing Sacituzumab Govitecan to physician's choice in locally advanced or metastatic unresectable urothelial cancer has com…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-06-02Clinical Trial Update: Study of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread [Phase 3]
Phase 3 trial comparing Sacituzumab Govitecan to physician's choice in locally advanced or metastatic unresectable urothelial cancer has com…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: BCG for Therapeutic Use Phase Ⅲ Clinical Trial [Phase 3]
Phase 3 clinical trial update for therapeutic use of BCG; the study is active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: The Personal Patient Profile Decision Support for Patients With Bladder Cancer [NA]
This clinical trial update notes that the Personal Patient Profile Decision Support tool for bladder cancer has completed, with results post…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Cancer in Patients on Dapagliflozin and Other Antidiabetic Treatment
A completed clinical trial evaluating cancer outcomes in patients treated with dapagliflozin in addition to other antidiabetic therapies.
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Impact Advanced Recovery® for Radical Cystectomy (RC) Patients: a Pilot Study [EARLY_Phase 1]
A pilot Phase 1 trial evaluating Impact Advanced Recovery for patients undergoing radical cystectomy for bladder cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG
Expanded-access treatment program for the investigational gene therapy Cretostimogene Grenadanorepvec to treat non-muscle-invasive bladder c…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer [Phase 2]
A Phase 2 study is testing pembrolizumab added to intravesical gemcitabine for BCG-unresponsive non-muscle invasive bladder cancer, with the…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Study of Erdafitinib Intravesical Delivery System in Japanese Participants With Bladder Cancer [Phase 1]
Phase 1 study evaluating an intravesical delivery system of erdafitinib in Japanese patients with bladder cancer.
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
ESPERANZA is an external control arm study of trastuzumab deruxtecan (T-DXd) for patients with HER2 IHC3+ solid tumors, sponsored by AstraZe…
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: Closed-System Bladder Irrigation to Reduce Urinary Tract Infections After Endoscopic Urologic Surgery (IRIS Trial) [NA]
The IRIS trial evaluating closed-system bladder irrigation to reduce postoperative urinary tract infections after endoscopic urologic surger…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: A Study to Determine if Mesh Placement During Bladder Surgery Can Reduce the Chances of Developing a Hernia [Phase 3]
A Phase 3 trial evaluating mesh placement during radical cystectomy to reduce post-operative hernias has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Sacituzumab Govitecan, Preceding Radical Cystectomy, in Treating Patients With Muscle-invasive Bladder Cancer [Phase 2]
Phase 2 study evaluating sacituzumab govitecan as neoadjuvant therapy before radical cystectomy for muscle-invasive bladder cancer has compl…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma [Phase 1]
Phase 1 clinical trial evaluating dual-target Nectin-4/HER2 CAR-NK cells for advanced urothelial carcinomas, including bladder cancer, is cu…
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer [Phase 1, Phase 2]
A study of Enfortumab Vedotin, alone or with other therapies, for urothelial cancers has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: A Study to Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer [Phase 1]
A Phase 1 study of PF-07921585 alone or with other anti-cancer medicines in multiple cancers has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Evaluation of VISIOCYT Bladder Cytology in Real Life
A completed clinical trial evaluating VISIOCYT bladder cytology for real-world performance in bladder cancer.
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Recovery Support for Bladder Cancer Patients and Caregivers [NA]
Completed clinical trial evaluating recovery support for bladder cancer patients and their caregivers, focusing on patient engagement and em…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies [Phase 1, Phase 2]
Phase 1/2 trial of plinabulin with radiation and immunotherapy in select advanced cancers after progression on PD-1/PD-L1 therapy was termin…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: COMPARISON OF OBTURATOR NERVE BLOCK TECHNIQUES IN TURBT [NA]
A completed clinical trial comparing obturator nerve block techniques used during transurethral resection of bladder tumor in bladder cancer…
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Study Investigating Intravesical HDAC Inhibition to Improve Response to Immuno-Oncology Agents [Phase 1]
A Phase 1 study evaluating intravesical HDAC inhibition to enhance response to immuno-oncology agents in bladder cancer has been suspended.